InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
T+90 hit rate
0%
T+90 mean return
-44.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Brennan Aoife, Director. Insider active across 3 companies, notably FIBROGEN INC. Cumulatively, 10 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €30k. Activity tracked since 26 May 2021. The latest transaction was filed on 7 June 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations10 total
68,750 sharesCommon StockSEC:0001193125-26-291131:0
30,902 sharesCommon StockSEC:0001193125-26-291131:1
8,289 shares0Common StockSEC:0001209191-23-036080:0
19,042 shares@ US$0.575833.6% of flowCommon StockSEC:0000899243-23-010715:0
15,777 shares0Common StockSEC:0001209191-22-038603:0
8,894 shares@ US$2.44590.15% mcap100.0% of flowCommon StockSEC:0000899243-22-014110:0
106,920 shares0Common StockSEC:0000899243-22-005213:0
106,920 shares0Common StockSEC:0000899243-22-005213
4,700 shares0Common StockSEC:0001209191-21-036668:0
4,700 shares0Common StockSEC:0001209191-21-036668
10 of 10 declarations
About Brennan Aoife
Aoife Brennan is a Director at FibroGen Inc and Synlogic, Inc. She brings valuable expertise in the biotechnology and healthcare sectors. As a board member, Aoife plays a key role in the governance of the companies, participating in strategic decision-making that influences their direction and performance. Her experience in the sector enables her to contribute to discussions on innovation and the development of new treatments, thereby strengthening the companies' market position.
